Gender differences in plasma biomarker levels in a cohort of COPD patients: A pilot study

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  de Torres, Juan P ^a   Casanova, Ciro ^b   Pinto Plata, Victor ^c   Varo, Nerea ^a   Restituto, Patricia ^a   Cordoba Lanus, Elizabeth ^b   Baz Dávila, Rebeca ^b   Aguirre Jaime, Armando ^b   Celli, Bartolome R ^d  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; INTERLEUKIN 16; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN PARC; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; BETA CHEMOKINE; CCL18 PROTEIN, HUMAN; CCL2 PROTEIN, HUMAN; VASCULOTROPIN A;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; EXERCISE TOLERANCE; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; QUALITY OF LIFE; SEX DIFFERENCE; BLOOD; COHORT ANALYSIS; SEXUAL DEVELOPMENT; SMOKING;

BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHEMOKINES, CC; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-16; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MATRIX METALLOPROTEINASE 9; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX CHARACTERISTICS; SEX FACTORS; SMOKING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79251574405     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016021     Document Type: Article

References (28)

1. Jamal A, Ward E, Hao Y (2005) Trends in the leading causes of death in the United States, 1970-2002. JAMA 294: 1255-9.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC (2002) Chronic Pulmonary Disease Surveillance- United States, 1971-2000. MMWR 51: SS6.
3. Becklake MR, Kauffmann F (1999) Gender differences in airway behaviour over the human life span. Thorax 54: 1119-1138.
4. de Torres JP, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, et al. (2005) Gender and COPD in patients attending a pulmonary clinic. Chest 128: 2012-6.
5. Di Marco F, Verga M, Reggente M, María Casanova F, Santus P, et al. (2006) Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 100: 1767-74.
6. de Torres JP, Cote CG, López MV, Casanova C, Diaz O, et al. (2009) Sex differences in Mortality in Patients with COPD. Eur Respir J 33: 528-35.
7. Gan WQ, Man SF, Senthiselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and meta-analysis. Thorax 59: 574-580.
8. de Torres JP, Cordoba-Lanus E, López-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, et al. (2006) C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 27: 902-907.
9. Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, et al. (2007) Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 62: 595-601.
10. Agustí AGN, Noguera A, Sauleda J, Sala E, Pons J, et al. (2003) Systemic effects of chronic obstructive pulmonary disease. Eur Resp J 21: 347-360.
11. Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, et al. (2009) Serum biomarkers as predictors of lung function decline in COPD. Respir Med 103: 1231-1238.
12. Sin DD, Man SF (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107(11): 1514-9.
13. Houghton AM, Mouded M, Shapiro SD (2008) Common origins of lung cancer and COPD. Nat Med 14: 1023-1024.
14. Celli BR, Cote C, Marin JM, Casanova C, Montes de Oca M, et al. (2004) The Body Mass Index, Airflow Obstruction, Dyspnea, Exercise Performance (BODE) Index in Chronic Obstructive Pulmonary Disease. N Engl J Med 350: 1005-1012.
15. Celli BR, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23: 932-946.
16. Charlson M, Szatrowsky T, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47: 1245-1251.
17. ATS Statement: Guidelines for the Six-Minute Walk Test (2002) Am J Respir Crit Care Med 166: 111-117.
18. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, et al. (2004) The Inspiratory to Total Lung Capacity Ratio Predicts Mortality in Patients with COPD. Am J Respir Crit Care Med 171: 591-597.
19. Brooks SM (1982) Surveillance for respiratory hazards. ATS News 8: 12-16.
20. Cartier A, Côte M, Lemieux I, Pérusse L, Tremblay A, et al. (2009) Sex differences in inflammatory markers: what is the contribution of visceral adiposity. Am J Clin Nutr 89: 1307-14.
21. Ben-Zaken Cohen S, Paré PD, Paul Man SF, Sin DD (2007) The growing burden of Chronic Obstructive Pulmonary Disease and lung Cancer in Women. Examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med 176: 113-120.
22. Henschke CI, Yip R, Miettinen OS (2006) Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. International Early Lung Cancer Action Program Investigators. JAMA 296: 180-4.
23. Xu X, Li B, Wang L (1994) Gender difference in smoking effects on adult pulmonary function. Eur Respir J 7: 477-483.
24. Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, et al. (2004) Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170: 1286-93.
25. Di Marco F, Verga M, Reggente M, Casanova MF, Santus P, et al. (2006) Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 100: 1767-74.
26. Barnes PJ (2009) The cytokine network in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol 41: 631-638.
27. Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Reale M, et al. (2002) Interleukin-16 network in inflammation and allergy. Allergy Asthma Proc 23: 103-8. Review.
28. Marwick JA, Edirisinghe I, Arunachalam G, Stevenson CS, Macnee W, et al. (2010) Cigarette smoke regulates VEGFR2-mediated survival signaling in rat lungs. J Inflamm (Lond) 7: 11.